Reproductive and fertility tests help identify hormone levels that affect conception and reproductive health. Bids Chemist provides discreet, reliable testing for both men and women. These insights can uncover hormonal imbalances or fertility challenges, helping you plan effectively for pregnancy or improve reproductive wellness with medical guidance.
This test measures antimullerian hormone (AMH), which reflects ovarian reserve and fertility potential. Blood is drawn, and results guide fertility assessment, family planning, and reproductive treatment decisions. Understanding AMH levels allows healthcare providers to counsel patients on fertility options, timing of interventions, and treatment planning. Early awareness of ovarian reserve supports informed decisions, optimised reproductive outcomes, and monitoring of age-related fertility changes. Patients gain insights into their reproductive health and can take proactive steps to achieve their family planning goals.
This test measures beta HCG quantitatively in blood to confirm pregnancy and estimate gestational age. Blood is collected and analysed to monitor hormone levels, guide prenatal care, and detect potential complications early. Quantitative measurement allows healthcare providers to track pregnancy progression, evaluate for ectopic or non-viable pregnancies, and support patient counseling. Patients benefit from accurate, early detection and informed reproductive health decisions.
This test involves cervical cytology, commonly known as a Pap smear, which screens for abnormal cells in the cervix. Cells are collected from the cervix and examined microscopically to detect precancerous changes or infection. Regular screening allows healthcare providers to identify abnormalities early, guide treatment, and prevent progression to cervical cancer. Patients benefit from early detection, peace of mind, and improved long-term reproductive health.
This test combines cervical cytology with high-risk HPV testing (types 16, 18, and others). Cells are collected from the cervix and analysed for abnormal cellular changes and HPV infection, which is a major cause of cervical cancer. Early detection allows healthcare providers to provide targeted monitoring, treatment, and preventive strategies. Patients benefit from comprehensive screening, early intervention, and long-term reproductive health protection.
This profile evaluates erectile dysfunction causes, including hormonal, vascular, or metabolic factors. Blood is drawn to measure hormones such as testosterone, prolactin, and others. Results help healthcare providers identify underlying causes, guide treatment plans, and monitor therapy response. Patients benefit from understanding contributing factors, receiving tailored interventions, and improving sexual and overall health.
This profile measures key female hormones including FSH, LH, estradiol, progesterone, and AMH to evaluate reproductive health, ovarian reserve, and menstrual cycle function. Blood is collected and analysed to identify hormonal imbalances, assess fertility potential, or diagnose reproductive disorders. Elevated or low hormone levels can indicate conditions such as polycystic ovary syndrome (PCOS), premature ovarian failure, or irregular cycles. Understanding results allows healthcare providers to guide treatment, fertility planning, or lifestyle interventions, including diet and exercise adjustments. Patients benefit by gaining insight into reproductive health, planning family goals, and implementing proactive measures to optimise fertility and hormonal balance. Early detection of abnormalities supports timely intervention, improving long-term reproductive and overall health outcomes.
This test measures follicle-stimulating hormone (FSH), a key regulator of ovarian and testicular function. Blood is collected to evaluate reproductive hormone balance, ovarian reserve, and menstrual cycle health. Abnormal levels may indicate infertility, menopause, or hormonal disorders. Healthcare providers use results to guide fertility treatments, hormone therapy, or lifestyle recommendations. Patients benefit by understanding reproductive hormone status, optimising fertility potential, and making informed decisions regarding family planning and long-term hormonal health. Timely detection allows early intervention and personalised care planning.
Measures hormones influenced by hormone replacement therapy, including estrogen and progesterone. Used to monitor therapy effectiveness, adjust doses, and assess symptom relief. Blood is drawn, and results are interpreted alongside clinical symptoms. Understanding hormone levels helps patients and healthcare providers optimise therapy and improve quality of life.
Inhibin B is a hormone produced by the ovaries (or testes) that reflects fertility status. Low levels in women may indicate reduced ovarian reserve, while in men, it can indicate testicular function. It is used in fertility assessments, assisted reproduction planning, and monitoring reproductive health. Blood is collected via venipuncture, usually in the morning. Results are interpreted alongside other hormones like FSH, AMH, and estradiol. Understanding inhibin B levels helps patients make informed decisions about family planning, fertility treatments, or lifestyle interventions to optimise reproductive health outcomes.
Measures LH, a hormone regulating reproductive function in both men and women. In women, it triggers ovulation; in men, it stimulates testosterone production. Blood is drawn, typically in the morning or during specific cycle phases. Abnormal levels can indicate infertility, hormonal imbalances, or pituitary disorders. Results guide fertility assessments, treatment planning, and monitoring of reproductive health. Understanding LH levels allows patients to optimise fertility, manage hormonal disorders, and make informed reproductive health decisions.
This profile measures key male hormones, including testosterone, luteinising hormone (LH), and follicle-stimulating hormone (FSH), to assess reproductive and endocrine health. Blood is collected to evaluate fertility potential, sexual function, and metabolic status. Abnormal hormone levels may indicate hypogonadism, infertility, or endocrine disorders, which can affect energy, mood, and overall health. Results enable healthcare providers to develop personalised treatment plans, including lifestyle modifications, hormone therapy, or fertility interventions. Patients benefit by understanding their hormone levels, optimising reproductive and sexual health, and taking proactive steps to prevent long-term metabolic or cardiovascular complications. Early evaluation supports informed decision-making, guided interventions, and improved long-term wellness for men concerned about hormonal balance or reproductive function.
This advanced male sexual health profile evaluates multiple physiological markers affecting sexual function, libido, and reproductive health. Blood is drawn to measure hormone levels, metabolic indicators, and other relevant biomarkers. Results help healthcare providers identify underlying causes such as low testosterone, vascular issues, or endocrine imbalances. Early detection allows tailored treatment, which may include lifestyle interventions, medications, or fertility support. Patients benefit by understanding their sexual health status, addressing potential concerns proactively, and improving long-term reproductive and metabolic wellness. Comprehensive testing provides actionable insights, enabling personalised care, preventive strategies, and informed decision-making to optimise sexual function, reproductive capacity, and overall quality of life.
This test evaluates key hormones associated with menopause, including estrogen, FSH, and LH, to assess menopausal status, symptoms, and risks for related conditions such as osteoporosis or cardiovascular disease. Blood is collected and analysed to guide healthcare providers in recommending hormone therapy, lifestyle interventions, or preventive care. Patients benefit by understanding hormonal changes, managing symptoms effectively, and maintaining long-term health. Early assessment allows tailored interventions, monitoring of risk factors, and improved quality of life through informed healthcare decisions and proactive management of menopausal transitions.
This test measures estradiol (E2), a key female sex hormone regulating reproductive health, menstrual cycle, bone metabolism, and cardiovascular function. Blood is collected and analysed to evaluate hormonal balance, fertility status, or menopausal changes. Abnormal levels may indicate ovarian dysfunction, endocrine disorders, or reproductive concerns. Results help healthcare providers guide hormone therapy, fertility planning, or monitoring strategies. Patients benefit by understanding their hormone status, optimising reproductive and bone health, and implementing preventive interventions. Timely assessment allows early detection of imbalance, supporting informed decision-making, symptom management, and long-term wellness. Maintaining appropriate estradiol levels is critical for metabolic, reproductive, and overall health.
This test measures oestrone, an estrogen hormone involved in reproductive and bone health. Blood is collected and analysed to evaluate hormonal balance, menopause, fertility, or endocrine disorders. Abnormal oestrone levels can impact menstrual cycle regularity, fertility, bone density, and metabolic function. Healthcare providers use results to guide hormone therapy, supplementation, or lifestyle interventions. Patients benefit by understanding estrogen status, preventing complications, optimising reproductive and skeletal health, and supporting overall wellness. Early detection of hormonal imbalances enables timely intervention, proactive management, and informed healthcare decisions, improving long-term health outcomes and quality of life.
This quantitative pregnancy test measures beta hCG in blood to detect early pregnancy. Blood is collected and analysed to determine pregnancy status, monitor early gestation, and assess potential complications. Results help healthcare providers guide prenatal care, monitor hormone levels, and provide counseling. Patients benefit by confirming pregnancy, receiving timely guidance, and supporting maternal and fetal health. Early detection allows informed decisions and proactive prenatal care.
This test measures progesterone levels, a hormone critical for reproductive health, menstrual cycle regulation, and pregnancy maintenance. Blood is collected and analysed to evaluate fertility, luteal phase adequacy, or hormonal imbalance. Abnormal levels can impact ovulation, pregnancy outcomes, and general well-being. Healthcare providers use results to guide fertility planning, hormone therapy, or lifestyle interventions. Patients benefit by understanding hormonal status, supporting reproductive health, improving fertility outcomes, and maintaining long-term wellness. Timely assessment allows personalised care, symptom management, and proactive strategies to optimise endocrine function.
This test evaluates sexual health markers in blood, including hormones and metabolic indicators, to assess reproductive function and overall well-being. Blood is collected and analysed to identify underlying issues affecting libido, fertility, or endocrine balance. Results help healthcare providers recommend treatment, lifestyle adjustments, or further testing. Patients benefit by understanding sexual and reproductive health, optimising function, and maintaining long-term wellness. Timely evaluation supports proactive management and informed decision-making.
This test evaluates multiple testosterone-related markers in a comprehensive profile. Blood is collected and analysed to assess hormone levels, endocrine function, fertility, and sexual health. Abnormal results allow healthcare providers to guide therapy, supplementation, and lifestyle interventions. Patients benefit by understanding hormonal balance, optimising reproductive and metabolic health, and supporting long-term wellness. Timely assessment ensures proactive management and informed decisions regarding endocrine health.
This test measures testosterone in patients on replacement therapy to monitor effectiveness and safety. Blood is collected and analysed to assess hormone levels, adjusting dosing as needed. Abnormal levels may indicate over- or under-treatment. Healthcare providers use results to optimise therapy, prevent side effects, and ensure efficacy. Patients benefit by maintaining symptom control, supporting reproductive and metabolic health, and promoting long-term wellness. Timely monitoring ensures safe and effective hormone replacement.
